41
In band
Moving averages
SMA 200$53.28-2.72%
Company profile
CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.
SectorHealthcare
IndustryBiotechnology
Market cap$5.00B
P/E ratioNone
EPS$-4.71
Beta1.76
Dividend yield0.00%
52-week high$78.48
52-week low$44.12
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 48
VRTX
Vertex Pharmaceuticals Inc
RSI 46
IOVA
Iovance Biotherapeutics Inc
RSI 69
MRNA
Moderna Inc
RSI 62
VKTX
Viking Therapeutics Inc
RSI 40
SRPT
Sarepta Therapeutics Inc
RSI 55
EDIT
Editas Medicine Inc
RSI 43
NVAX
Novavax Inc
RSI 57
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 46
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 53
RSI alerts for CRSP
Get an email the moment Crispr Therapeutics AG crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 2:19 AM EDT